2. TRUXIMA® (rituximab-abbs) Prescribing Information. Incheon, Republic of Korea: Celltrion, Inc. 3. Rituxan® (rituximab) full Prescribing Information. South San Francisco, CA: Genentech, Inc., December 2021. 4. US Food and Drug Administration. Labeling for biosimilar products. Guidance for...
“The approval of TRUXIMA is a significant milestone for Celltrion and, more notably, for the patients who need access to this important medication,” said Woosung Kee, Chief Executive Officer of Celltrion. “TRUXIMA is the very first rituximab biosimilar ...